Test Results
|
Proven Effective Against Staph. aureus, MRSA, Strep. pyogenes, Pseudomonas aeruginosa, E. coli 0157-H7, Salmonella choleraesuis, Campylobacter jejuni, Listeria monocytogenes, Norovirus, HIV, Candida albicans, Aspergillus niger and many more. Advanced Biomedical, Inc. utilizes a unique and proprietary methodology to create the formulation for our new and vastly superior hand sanitizing lotion, DuraShield®. Independent testing data shows that not only does it offer the initial killing capabilities of the alcohol-based hand sanitizers on the market, but it offers the distinct advantage of protecting against a wider range of pathogens for extended periods after application. This is dramatically superior to the alcohol-based products whose effectiveness stops as soon as the alcohol dries. Additional independent testing demonstrates that DuraShield® can be applied less frequently, providing convenience of use and an overall cost reduction to the supplier. |
|
Proven Effective Against Staph. aureus, MRSA, Strep. pyogenes, Pseudomonas aeruginosa, E. coli 0157-H7, Salmonella choleraesuis, Campylobacter jejuni, Listeria monocytogenes, Norovirus, HIV, Candida albicans, Aspergillus niger and many more. Advanced Biomedical, Inc. utilizes a unique and proprietary methodology to create the formulation for our new and vastly superior hand sanitizing lotion, DuraShield®. Independent testing data shows that not only does it offer the initial killing capabilities of the alcohol-based hand sanitizers on the market, but it offers the distinct advantage of protecting against a wider range of pathogens for extended periods after application. This is dramatically superior to the alcohol-based products whose effectiveness stops as soon as the alcohol dries. Additional independent testing demonstrates that DuraShield® can be applied less frequently, providing convenience of use and an overall cost reduction to the supplier. |
